Rebastinib (DCC-2036)

  • Catalog number
    B1619-25
  • Price
    Please ask
  • Size
    25 mg
  • Alternative_name
    DCC-2036; DCC-2036; DCC2036; Bcr-Abl inhibitor; Bcr-abl inhibitor; 4-[4-[(5-tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
  • Description
    DCC-2036 (Rebastinib) is an inhibitor of Bcr-Abl with IC50 of 0.8 nM and 4 nM for Abl1(WT) and Abl1(T315I), respectively.
  • CAS Number
    1020172-07-9
  • Structure Available
    Yes
  • Salt Form
    No
  • Molecular Formula
    C₃₀H₂₈FN₇O₃
  • Molecular Weight
    553.59
  • Cell Permeable
    Yes
  • Purity
    >98%
  • Solubilities
    DMSO
  • Handling
    Protect from air and light
  • Tag Line
    A Bcr-Abl inhibitor
  • Storage Condition
    -20°C
  • Shipping Condition
    gel pack
  • Shelf Life
    36 months
  • MDL Number
    MFCD19443646
  • PubChem CID
    25066467
  • SMILES
    CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5
  • InChi
    1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)
  • InChi Key
    WVXNSAVVKYZVOE-UHFFFAOYSA-N
  • MSDS Available
    Yes
  • Gene target
  • Gene symbol
    DCC
  • Short name
    Rebastinib (DCC-2036)
  • Alternative name
    Rebastinib (deleted in colorectal carcinoma-2036)
  • Alternative to gene target
    deleted in colorectal carcinoma, CRC18 and CRCR1 and IGDCC1 and MRMV1 and NTN1R1, DCC and IDBG-3511 and ENSG00000187323 and 1630, identical protein binding, Plasma membranes, Dcc and IDBG-157336 and ENSMUSG00000060534 and 13176
Gene info
Similar products
Filters
Contact
Chat with gentaur.com employee